Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BELANTAMAB MAFODOTIN vs BEMPEDOIC ACID: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BELANTAMAB MAFODOTIN vs BEMPEDOIC ACID: Safety Overview

Metric BELANTAMAB MAFODOTIN BEMPEDOIC ACID
Total FAERS Reports 2,293 1,702
Deaths Reported 843 6
Death Rate 36.8% 0.4%
Hospitalizations 599 121
Average Patient Age 67.3 yrs 67.5 yrs
% Female Patients 39.2% 62.7%
FDA Approval Date N/A Feb 21, 2020
Manufacturer GlaxoSmithKline LLC Esperion Therapeutics, Inc.
Route INTRAVENOUS ORAL
Marketing Status N/A Prescription